Scholtz & Company, LLC Medpace Holdings, Inc. Transaction History
Scholtz & Company, LLC
- $207 Million
- Q3 2024
A detailed history of Scholtz & Company, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Scholtz & Company, LLC holds 1,466 shares of MEDP stock, worth $494,452. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,466
Previous 1,671
12.27%
Holding current value
$494,452
Previous $688,000
29.07%
% of portfolio
0.24%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding MEDP
# of Institutions
616Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$870 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$858 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$306 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$254 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$212 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.5B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...